I'm from the FDA and I'm here to help

FDA says, "no way, man" to marijuana, but here is a story about a drug the FDA said "Oh, yes" to.

FDA probing death linked to new antibiotic

Other cases of severe liver damage reported in patients taking drug

Updated: 12:37 p.m. ET Jan. 20, 2006

WASHINGTON - Researchers reported Friday three cases of severe liver problems, including one death, in patients at a North Carolina hospital after they began taking a novel antibiotic.

Federal regulators said they were reviewing an unknown number of U.S. cases involving the drug, telithromycin, and were consulting with their counterparts overseas.

One patient at Carolinas Medical Center in Charlotte, N.C., died after taking telithromycin, which is marketed as Ketek, researchers at the hospital said. Another required and received a liver transplant, while the third recovered from drug-induced hepatitis after treatment with Ketek was stopped.